Clinical trial · Observational
Analysis of Blood During Surgery for Musculoskeletal Tumors
Cellular Analysis of Blood Suctioned During Surgery for Musculoskeletal Tumors
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Why stopped (as posted): investigators felt sufficient data has been collected
Summary
Brief summary (as posted)
This study is being done as the doctor investigators would like to lessen the amount of blood transfusions given to patients. Patients who receive blood transfusions have a greater chance of developing complications after surgery. There is a device called the Cell Saver that allows the doctors to process blood that is lost during surgery and return it to the patient. This lessens the amount of transfused blood the patients receive. This device is not used for patients undergoing surgery for muscular skeletal tumors.The investigators are not sure whether tumor cells are present in the blood which is lost during the course of an operation like yours. The goal of this study is to see if we lessen the amount of blood transfusions given to patients who may have tumor or cancerous cells present in their blood. One way to do this is to test the blood that is circulating in your veins and also to test the blood which is lost during the course of your operation
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Musculoskeletal Tumors | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (1)
- label
- musculoskeletal tumors
- description
- all patients undergoing surgery for musculoskeletal tumors
Primary outcomes (1)
- measure
- presence of tumor cells in the operative field
- timeFrame
- intraoperatively
- description
- specimens taken twice from operative field; once just prior to removal of tumor and the second just after tumor removal.
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 90 Years
Show eligibility criteria text
Inclusion Criteria: * all patients undergoing orthopedic surgery for musculoskeletal tumors Exclusion Criteria: * pts who are pregnant
References
Publications (0)
Data not yet available